BioCentury
ARTICLE | Clinical News

Evotaz atazanavir/cobicistat regulatory update

July 20, 2015 7:00 AM UTC

The European Commission approved an MAA from Bristol-Myers Squibb for Evotaz atazanavir/cobicistat in combination with other antiretroviral agents to treat HIV-1 infection in adults without known muta...